Dariohealth presents new research demonstrating the impact of a digital solution on depression and anxiety at the american psychological association annual convention

The studies underscore the value of dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs new york , aug. 4, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today new research presented at the american psychological association ("apa") annual convention being held august 4 th to 6th, 2022 in minneapolis, minnesota and virtually. people living with chronic conditions are 2 to 3 times more likely to experience depression or anxiety than those living without a chronic illness, and untreated depression or anxiety often leads to poor health outcomes.
DRIO Ratings Summary
DRIO Quant Ranking